[
  {
    "ts": null,
    "headline": "Why Is Merck Stock Trading Higher On Monday?",
    "summary": "On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension (PAH, WHO Group 1) functional class (FC) III or IV at high risk of mortality. PAH is high blood pressure in pulmonary arteries, which carry oxygen-poor blood from the heart to the lungs. ZENITH met its primary endpoint of time to first morbidity or mortality event (all-cause death, lung transplantation, or PAH worsening",
    "url": "https://finnhub.io/api/news?id=4adc397ab77c95c44794aa1ad876431799b4bca3fa29922b5e582af194dead01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732554143,
      "headline": "Why Is Merck Stock Trading Higher On Monday?",
      "id": 131630425,
      "image": "https://media.zenfs.com/en/Benzinga/71efa18165aca5dc85eae482edba95f7",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension (PAH, WHO Group 1) functional class (FC) III or IV at high risk of mortality. PAH is high blood pressure in pulmonary arteries, which carry oxygen-poor blood from the heart to the lungs. ZENITH met its primary endpoint of time to first morbidity or mortality event (all-cause death, lung transplantation, or PAH worsening",
      "url": "https://finnhub.io/api/news?id=4adc397ab77c95c44794aa1ad876431799b4bca3fa29922b5e582af194dead01"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=47abbe1fd86b9432a96fa400620ca3e1d388ab4cba918d630947f1f9e6f4caf6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732552500,
      "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "id": 131636898,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=47abbe1fd86b9432a96fa400620ca3e1d388ab4cba918d630947f1f9e6f4caf6"
    }
  },
  {
    "ts": null,
    "headline": "Sherwin-Williams Co., Nike share gains lead Dow's 350-point jump",
    "summary": "Sherwin-Williams Co., Nike share gains lead Dow's 350-point jump",
    "url": "https://finnhub.io/api/news?id=db0a6bb1bfe3b479b00f7da65914013430549302c49931d3b3d0c7d4cf7b015f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732541580,
      "headline": "Sherwin-Williams Co., Nike share gains lead Dow's 350-point jump",
      "id": 131636029,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Sherwin-Williams Co., Nike share gains lead Dow's 350-point jump",
      "url": "https://finnhub.io/api/news?id=db0a6bb1bfe3b479b00f7da65914013430549302c49931d3b3d0c7d4cf7b015f"
    }
  },
  {
    "ts": null,
    "headline": "Nike, Sherwin-Williams Co. share gains lead Dow's nearly 250-point jump",
    "summary": "Nike, Sherwin-Williams Co. share gains lead Dow's nearly 250-point jump",
    "url": "https://finnhub.io/api/news?id=a9fd952cf1b32f68659bbb4b25b6597e13e25b359d49204f0a470d96c685668e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732537740,
      "headline": "Nike, Sherwin-Williams Co. share gains lead Dow's nearly 250-point jump",
      "id": 131636030,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Nike, Sherwin-Williams Co. share gains lead Dow's nearly 250-point jump",
      "url": "https://finnhub.io/api/news?id=a9fd952cf1b32f68659bbb4b25b6597e13e25b359d49204f0a470d96c685668e"
    }
  },
  {
    "ts": null,
    "headline": "New data could help Merck expand use of cardiovascular drug",
    "summary": "Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade.",
    "url": "https://finnhub.io/api/news?id=73d4063c9629ad8240910cbb0ab3a3b87b70f56f629f21d877402cec4777f6dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732535820,
      "headline": "New data could help Merck expand use of cardiovascular drug",
      "id": 131630426,
      "image": "https://imgproxy.divecdn.com/cjRPdKXRnmSQBII-kQAJxYmdwWNgtOOQ0TEk1mcWRto/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy01NjI5MzE4M19oMHBuUjJRLmpwZw==.webp",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade.",
      "url": "https://finnhub.io/api/news?id=73d4063c9629ad8240910cbb0ab3a3b87b70f56f629f21d877402cec4777f6dd"
    }
  },
  {
    "ts": null,
    "headline": "Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis",
    "summary": "RAHWAY, N.J., November 25, 2024--Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis",
    "url": "https://finnhub.io/api/news?id=42555fa27f1f344ae01957bada06274a73947af703842dc74d299043252c0810",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732535100,
      "headline": "Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis",
      "id": 131630427,
      "image": "https://media.zenfs.com/en/business-wire.com/d46548af9de28fd6f7411be3dfa91518",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., November 25, 2024--Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis",
      "url": "https://finnhub.io/api/news?id=42555fa27f1f344ae01957bada06274a73947af703842dc74d299043252c0810"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 482-point rally led by gains for Boeing, Amazon.com Inc. stocks",
    "summary": "Dow's 482-point rally led by gains for Boeing, Amazon.com Inc. stocks",
    "url": "https://finnhub.io/api/news?id=a252a32fec1123839ee946fd88069f31d177809b854f5a00adbfd4b08e69ced2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732527900,
      "headline": "Dow's 482-point rally led by gains for Boeing, Amazon.com Inc. stocks",
      "id": 131635560,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow's 482-point rally led by gains for Boeing, Amazon.com Inc. stocks",
      "url": "https://finnhub.io/api/news?id=a252a32fec1123839ee946fd88069f31d177809b854f5a00adbfd4b08e69ced2"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds",
    "summary": "We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other promising cancer stocks. According to the World Health Organization (WHO), cancer remains one of the leading causes of death […]",
    "url": "https://finnhub.io/api/news?id=ceacd2b4b63b4d3ad5fcc767f5545df32f444de22de854e882caf49bf4b47053",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732526579,
      "headline": "Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds",
      "id": 131622881,
      "image": "https://s.yimg.com/ny/api/res/1.2/krpa0cobX2AdeFb7DJ59pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other promising cancer stocks. According to the World Health Organization (WHO), cancer remains one of the leading causes of death […]",
      "url": "https://finnhub.io/api/news?id=ceacd2b4b63b4d3ad5fcc767f5545df32f444de22de854e882caf49bf4b47053"
    }
  },
  {
    "ts": null,
    "headline": "Merck: successful study in arterial hypertension",
    "summary": "Merck announced on Monday that a Phase III clinical trial had met its primary endpoint in patients with pulmonary arterial hypertension.The pharmaceutical group explains that the study involved...",
    "url": "https://finnhub.io/api/news?id=208c745b965f42aec46a923d4e9c666796d4089f62a3b2e29112742a3dacb338",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732522036,
      "headline": "Merck: successful study in arterial hypertension",
      "id": 131623967,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck announced on Monday that a Phase III clinical trial had met its primary endpoint in patients with pulmonary arterial hypertension.The pharmaceutical group explains that the study involved...",
      "url": "https://finnhub.io/api/news?id=208c745b965f42aec46a923d4e9c666796d4089f62a3b2e29112742a3dacb338"
    }
  },
  {
    "ts": null,
    "headline": "Nvidia's Profit Ruled Last Quarter — Now It's These 8 Stocks' Turn",
    "summary": "Nvidia's Profit Ruled Last Quarter — Now It's These 8 Stocks' Turn",
    "url": "https://finnhub.io/api/news?id=730472227ecea3ede944a2e5b379b8679253821e0d6a7ee57d30c9cb33d31e11",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732521635,
      "headline": "Nvidia's Profit Ruled Last Quarter — Now It's These 8 Stocks' Turn",
      "id": 131636869,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "Nvidia's Profit Ruled Last Quarter — Now It's These 8 Stocks' Turn",
      "url": "https://finnhub.io/api/news?id=730472227ecea3ede944a2e5b379b8679253821e0d6a7ee57d30c9cb33d31e11"
    }
  }
]